Instructions to Authors
AUTHOR TUTORIAL (PRINTABLE VERSION)
COPYRIGHT TRANSFER STATEMENT (PRINTABLE VERSION)
HIP INTERNATIONAL publishes only peer-reviewed contributions, dealing with conservative hip surgery, traumatology of the hip, prosthetic surgery, biomechanics, and basic sciences relating to the hip
Hip International - Published bi-monthly
ISSN 1120-7000 - eISSN 1724-6067
INDEX MEDICUS / MEDLINE
CURRENT CONTENTS® / Clinical Medicine
SCISEARCH® / Science Citation Index Expanded
EMBASE / Excerpta Medica
Official Journal of the European Hip SocietyAffiliated with:Italian Hip SocietySpanish Hip SocietyArgentinian Association for the Study of Hip and KneeTurkish Arthroplasty SocietyBrazilian Hip Society
Reviews. Containing the current state of knowledge or practice, integrating recent advances with accepted principles and practice, or summarizing and analysing consensus view of controversial issues in knowledge of practice.
Original articles. Previously unpublished manuscripts describing clinical investigations, clinical observations, relevant clinical laboratory investigations. The text of articles must be divided into sections with the headings Introduction, Methods, Results and Discussion
Manuscripts should not exceed the following indications:
Max no. of figures
Letters to the Editor
1 or 1
*Including abstract and references but excluding tables and figures.
**HIP INTERNATIONAL offers complimentary publication of the number of pages indicated in the table.
Additional pages will be charged € 130,00 each directly by the Publisher and notified to the Corresponding Author with the proofs. Extra page charges do not apply to invited articles and Editorials.
Members of the European Hip Society and of the affiliated societies (SIA, SECCA, ACARO, SBQ, TOTBID) will be charged the reduced fee of Euro 100,00.
To protect its integrity and to ensure the most reliable information to its readers, Hip International will not consider manuscripts that have appeared, in part or in total, in other publications.
Likewise, updates of previously published studies that add little data to an existing publication will not be considered. Manuscripts submitted to Hip International must be an original contribution not previously published in any language or country (except as an abstract or preliminary report) and must not be under consideration for publication elsewhere.
The Editors are responsible for establishing and maintaining the highest possible standards of the Journal as well as for maintaining its integrity. The Editors and the Editorial Board are primarily responsible for ensuring a fair review process and will give unbiased consideration to all submitted manuscripts. The final responsibility rests with the authors, not with the Journal, its Editors, or the Publisher and the statements and opinions contained in the articles published in Hip International are solely those of the individual Authors and contributors.
If accepted, manuscripts must not be published elsewhere in similar form, in any language or country. Publication of the material elsewhere (duplicate publication) without permission of the Journal is a copyright infringement. Authors who violate ethical considerations such as duplication and plagiarism, will face disciplinary actions.
Authors who distribute e-print, preprints, reprints or content in any format including digital copies of an article before print publication may have their accepted manuscript rejected.
Each person listed as an author is expected to have participated in the study to a significant extent. To qualify for authorship, authors must have participated sufficiently in the work to take public responsibility for the content. The participation must include conception and design of the Manuscript, data acquisition or data analysis and interpretation, drafting of the manuscript and/or revising it for critically important intellectual content, revision of the manuscript and statistical analysis, obtaining funding, administrative, technical or material support, or supervision.
The Corresponding Author is the person responsible for a submission and all communication with the Journal regarding that submission. It is the Corresponding Author's responsibility to be sure that all Authors meet the required authorship criteria indicated above. The Corresponding author is expected to update regularly his/her personal information (email, telephone numbers, address) during the entire evaluation and publication process, as any enquiry on a manuscript is answered only to the Corresponding author.
Based on the definition of "guest authorship" as the designation and acknowledgment of an individual who does not meet authorship criteria and "ghost authorship" as the failure to designate an individual who has made a substantial contribution to the research or writing of a manuscript (see the paper in JAMA. 2008; 299 (15):1800-12), THE JOURNAL DOES NOT ALLOW GHOST AUTHORSHIP. If it comes to light that substantial contribution has not been disclosed, the Editor shall advise the corresponding author and withdraw the submission from the system.
The assistance of any guest authors, that is a person who has prepared a manuscript draft for the named authors to edit or if the named authors prepared the manuscript and received writing and formatting assistance can be acknowledged at the end of the manuscript, just above the references. If not self employed, the guest author should disclose the name of their employer and the funding source.
Once a manuscript has been submitted, the order of Authorship (including adding or removing Authors) CAN NOT be changed without a written request to the Editorial Office (email@example.com) from the Corresponding Author. A statement must be included in the request reporting that all authors are in agreement with the change. A new copyright transfer form, signed by all authors must be submitted. Both request and copyright transfer form must be signed by all authors. If an author is removed, a letter from that author agreeing to his/her removal is required. If there is any open questions regarding authorship please withdraw the paper. AUTHORSHIP CHANGES CAN NOT BE SUBMITTED WITH PROOF CHANGES. The publisher is not allowed to make such changes and it will delay the publication of your manuscript.
All manuscripts submitted for publication must be accompanied by the “Copyright Transfer and Authorship responsibility form”. This form states that each author owns the copyright or has written permission to use all the material in the article. This form must be downloaded from the journal’s website, completed in print, signed by the corresponding author on behalf of all authors, scanned and uploaded with the manuscript upon submission. If uploading is not possible, please FAX the form to +39 0255195971 as soon as possible. Your manuscript WILL NOT be processed until the Copyright Transfer Form, signed by all authors, is received.
If the manuscript submitted includes parts to which the authors do not own copyright, then a a written authorization from the copyright owner (usually the publisher) to use direct quotations, tables, or illustrations that have appeared in copyrighted form elsewhere, along with complete details about the original source. Give yourself ample time to request and receive permission. Any permissions fees that might be required by the copyright owner are the responsibility of the authors requesting use of the borrowed material not of Wichtig Editore or of Hip International.
It is the Authors' responsibility:
- - to protect patients' anonymity. When a patient is identifiable in a photograph, the Author(s) must supply the Journal with evidence of the patient's permission to publish the photograph. If necessary, Author(s) should mask the figure accordingly and remove names.
- - if manuscripts report the results of experimental investigation on human subjects, human derived materials, or human medical records, include a statement that the study was performed with informed consent and following all the guidelines for experimental investigation in human subjects required by the Institutional Review Board (IRB)/Ethics Committee of which all authors are affiliated.
Authors are required to disclose any sponsorship or funding arrangements relating to their research and any possible conflicts of interest. Financial interest is defined as any financial gain or expectancy of financial gain brought to the Author or to his/her family; ownership of stock options in a manufacturing company; involvement in any for-profit or not-for-profit corporation where the Author or his/her family is a director or recipient of a grant, including consultant and travel aid. Conflict of interest statements will be published in the article.
A number of research funding agencies now require authors to submit the article after publication to a repository that is accessible online by all without charge. Authors of such works should clearly indicated in the financial disclosures such funding. Post-publication means the article after peer review and acceptance but not the finished, copy-edited and proofed article.
Manuscripts must be submitted online at www.editorialmanager.com/hipint. Refer to the Author Tutorial supplied online which offers detailed instruction or initial and revised submission.
We strongly recommend that each time authors log in to the system they check the email address registered for correspondence.
If you have submitted a manuscript or acted as a reviewer for Hip International a username and password have been provided. The username and password are the same for any role you have in the system. If you cannot retrieve it or if you think you have registered before, please contact the Editorial Office (firstname.lastname@example.org) before you register again.
First-time users: Please click the Register button from the menu and enter the requested information. On successful registration, you will be sent an e-mail indicating your username and password. Print a copy of this information for future reference. If you wish to change any of the data in your profile, log in with your current username and password and update your profile. You only need to register once and should always use the same e-mail address.
Authors: Please click the log-in button from the menu at the top of the page and log into the system as an Author. Submit your manuscript according to the author instructions. Once you have initiated a submission you can leave it and continue later, as the system will save your information. The Corresponding Author will be able to track the progress of the submission through the system. Should you have any difficulties, please contact the Editorial Office (email@example.com).
HIP INTERNATIONAL adopts a double-blind peer review process. This means that Reviewers never have access to author information. When naming your files (manuscript, figures and copyright transfer form) please refrain from using Author’s names.
Upon submission you will be required to submit separate files for:
- Manuscript file, consisting of manuscript text, references, figure legends, tables
- Copyright Transfer Statement
1) Manuscript title: it should be meaningful and no longer than 135 characters (count letters and spaces). Avoid abbreviations in the title.2) Short title: no more than 75 characters (count letters and spaces) 3) Authors: listed as first name, initial and last name and complete with full Institutional affiliation 5) Corresponding author's information: Name, complete mailing address, telephone number, fax number and e-mail address of author to whom correspondence and request of reprints should be sent. This is usually the submitting author.6) Abstract: no longer than 250 words. The abstract should state the purposes of the study or investigation, basic procedures, main findings and the principal conclusions : provide and identify 3 to 6 key words Use terms from the Medical Subject Headings list from lndex Medicus whenever possible.
The following information will be required during the submission process:
You will also be required to supply information on the following statements and disclosures:1) a statement that the manuscript has been seen and approved by all authors and that it is not under consideration for publication elsewhere in a similar form, in any language, except in abstract form.
2) Disclosure on financial support: Identify all sources, public and private of grants and funds in support of the study. Supply the agency name and city, company name and city, fellowship name and grant number.
3) Disclosure on conflict of interest: A statement stating whether any authors have proprietary interest or not.
4) Disclosure in case of experimental investigation on human subjects of an Institutional Review Board (IRB)/Ethics Committee approval; a statement that the study was in adherence with the Declaration of Helsinky; a statement that informed consent was obtained by all participants.
5) Animal Experimentation: For all animal experimentation described in the manuscript, JN requires that authors state their adherence to the NIH Guide for the Care and Use of Laboratory Animals or the equivalent.
6) Clinical Trials Registration. For articles reporting on a clinical trial the Journal requires its prospective registration providing the Clinical Trial unique Registration number during the submission process.
7) Meeting presentation: If the paper was presented at a meeting, the name of the organisation, place and date on which it was read.
8) Membership to affiliated societies: State if any of the authors are members of the European Hip Society or of the affiliated societies (SIA, SECCA, ACARO, SBQ, TOTBID).
9) Acknowledgements: Acknowledge statistical consultation and assistance (when provided by a person different from the author) in an acknowledgement at the end of the article before the references. Indicate the name, degree and affiliation of the individual. For all others assisting in the preparation of a manuscript acknowledgements cannot be done, however valuable their service. Authors are responsible for obtaining written permission from everyone acknowledged by name because readers may infer their endorsement of the data and conclusions.
GUIDELINES FOR THE MANUSCRIPT FILE
Manuscripts that do not adhere to the following guidelines will be returned to the Corresponding Author for technical revision before undergoing the peer review process.
Type manuscript, preferably using Arial font size 12, double spaced on A4 size paper and number pages consecutively in the top right corner of each page.
Abbreviations: Use only standard abbreviations. The full term for which an abbreviation stands for should precede its first use in the text unless it is a standard unit of measurement.
The text of original, observational and experimental articles must be divided into sections with the headings lntroduction, Materials and Methods, Results, and Discussion. Long articles may need subheadings within some sections to clarify their contents, especially the Results and Discussion sections. Other types of articles such as reviews, case reports and editorials are likely to need other formats.
Introduction - Clearly state the purpose of the article. Summarize the rationale for the study or observation. Give only strictly pertinent references, and do not review the subject extensively.
Materials and Methods - Describe your selection of the observational or experimental subjects (patients or experimental animals, including controls) clearly. Identify the methods, apparatus (manufacturer’s name and address in parenthesis), and procedures in sufficient detail to allow other workers to reproduce the results. Give references to established methods, including statistical methods; provide references and brief descriptions of methods that have been published but are not well known; describe new or substantially modified methods, give reasons for using them, and evaluate their limitations. When reporting experiments on human subjects, indicate whether the procedures followed were in accord with the ethical standards of the committee on human experimentation of the institution in which the experiments were done or in accord with the Helsinki Declaration of 1975. When reporting experiments on animal subjects, indicate whether the institutions or the national research councils guide for the care and use of laboratory animals was followed. Identify precisely all drugs and chemicals used, including generic name(s), dosage(s), and route(s) of administration. Do not use patients name, initials, or hospital numbers.
Include numbers of observations and the statistical significance of the findings when appropriate. Detailed statistical analyses, mathematical derivations, and the like may sometimes be suitably presented in the form of one or more appendixes.
Results - Present your results in logical sequence in the text, tables, and illustrations. Do not repeat in the text all the data in the tables or illustrations, or both: emphasize or summarize only important observations.
Discussion - Emphasize the new and important aspects of the study and conclusions that follow from them. Do not repeat in detail data given in the Results section. Include the implications of the findings and their limitations and relate the observations to other relevant studies. Link the conclusions with the goals of the study but avoid unqualified statements and conclusions not completely supported by your data. Avoid claiming priority and alluding to work that has not been completed. State new hypotheses when warranted, but clearly label them as such. Recommendations, when appropriate, may be included.
References1. References should follow the text and begin on a separate page. 2. They must be double-spaced and numbered consecutively in order of appearance in the text, using the automatic numbering tool of Word3. Identify references in text, tables, and legends in Arabic numerals in parentheses, i.e. (7) and not in superscript.4. If there are 6 or fewer authors, all authors should be listed. If there are more than 6 authors, list the first three and then "et al"5. References used within tables should appear as footnotes in the table legend. These references should not be repeated in the main reference list unless they are also cited within the text.6. List only references pertinent to the manuscript, which you have read and that the reader can retrieve in a literature research.7. Journals’ names should be abbreviated according to Index Medicus/Medline (www.nlm.nih.gov/tsd/serials/lji.html). If there is any doubt about abbreviation of a journal name, it should be spelled out completely.8. All references must be verified by the Author(s) against the original documents. You may use the reference checking tool available at www.ncbi.nlm.nih.gov/entrez/query/static/citmatch.html.9. Cite only published studies as references. Personal communications, unpublished data, abstracts, oral or poster presentations should be limited and incorporated in parentheses within the text without a reference number. You may acknowledge “unpublished data” or “submitted” articles within parentheses in the text.10. Any references to studies (including books or articles) that have been accepted for publication, but not yet published, should indicate where they will be published and have the term "in press" in the reference in place of volume and page numbers. These must be updated prior to publication, if possible.11. Delete digits when in the same range: 534-7 or 1007-11 (NOT 534-537; 1007-1011)12. Do not add a discussion or comment to a reference. If applicable indicate it as Hip Int. 2007;17:534-7, Comment in: Hip Int. 2009;19:327; author reply 327.13. Suffixes such as Jr, Sr, and III follow authors initials
Reference formatting examples:
- Standard journal article - (List all authors when six or less; when seven or more, list only first three and add et al.).You CH, Lee KY, Chey WY, Menguy R. Electrogastrographic study of patients with unexplained nausea, bloating and vomiting. Gastroenterology 1980; 79: 311-4.
- Corporate author. The Royal Marsden Hospital Bone-Marrow Transplantation Team. Failure of syngeneic bone-marrow graft without preconditioning in post-hepatitis marrow aplasia. Lancet 1977; 2: 242-4.
- No author given. Anonymous. Coffee drinking and cancer of the pancreas (Editorial). Br Med J 1981; 283: 628.
- Journal supplement. Mastri AR. Neuropathy of diabetic neurogenic bladder. Ann Intern Med 1980; 92(2 Pt2): 316-8. Frumin AM, Nussbaum J, Esposito M. Functional asplenia: demonstration of splenic activity by bone marrow scan (Abstract). Blood 1979; 54 (suppl 1): 2 bat.
- Journal paginated by issue. Seaman WB. The case of the pancreatic pseudocyst. Hosp Pract 1981; 16 (Sep): 24-5.
- Personal author(s). Eisen HN. lmmunology: an introduction to molecular and cellular principles of the immune response. 5th ed. New York: Harper and Row, 1974; 406.
- Editor, compiler, chairman as author. Dausset J, Colombani J, eds. Histocompatibility testing 1972. Copenhagen: Munksgard, 1973; 12-8.
- Chapter in a book. Weinstein L, Swartz MN. Pathogenic properties of invading microorganisms. In: Sodeman WA Jr, Sodeman WA, eds. Pathologic physiology: mechanisms of disease. Philadelphia: W B Saunders 1974; 457-72.
- Published proceedings paper. DuPont B. Bone marrow transplantation in severe combined immunodeficiency with an unrelated MLC compatible donor. In: White HJ, Smith R, eds. Proceedings of the third annual meeting of the lnternational Society for Experimental Haematology. Houston: lnternational Society for Experimental Hematology 1974; 44-6.
- Monograph in a series. Hunninghake GW, Gadek JE, Szapiel SV, et al. The human alveolar macrophage. In: Harris CC ed. Cultured human cells and tissues in biomedical research. New York's Academic - Press, 1980; 54-6. (Stoner GD, ed. Methods and perspectives in cell, biology: vol 1).
- Agency publication. Ranofsky AL. Surgical operations in short-stay hospitals: United States - 1975. Hyattsville, Maryland: National Centre of Health Statistics, 1978; DHEW publication no. (PHS) 78-1785. (Vital and health statistics; series 13; no. 34). Dissertation or thesis. Carns RB. lnfrared spectroscopic studies of solid oxygen. Barkeley, California: University of California, 1965. 156 pp. Dissertation.
- Newspaper article. Shaffer RA. Advances in chemistry are starting to unlock mysteries of the brain: discoveries could help cure alcoholismand insomnia, explain mental illness. How the messengers work. Wall Street Journal 1977 Aug 12: 1 (col 1), 10 (col 1).
- Magazine article. Roueché B. Annals of medicine: the Santa Claus culture. The New Yorker 1971 Sep 4; 66-81.
Starting on a new page, type legends for figures double spaced, with Arabic numerals corresponding to the illustrations. All figures must have a legend. When symbols, arrows, numbers, or letters are used to identify parts of the illustrations, identify and explain each one clearly in the legend. Explain internal scale and identify method of staining in photomicrographs. Any figure that has been published elsewhere should have an acknowledgment to the original source; a copy of the release to publish the figure, signed by the copyright holder, must also be submitted.
Submit tables in your manuscript file and not as separate files. Place them after the references.
As a general rule, tables should not unnecessarily offer duplicate information given in the text. Starting on a new page type each table on a separate sheet, using double spacing. Tables should be created in a Word document using the table tools. Do not format tables as columns or tabs and do not submit tables as figures. Tables should be numbered consecutively in Roman numerals by order of citation in the text. Each table must include title, appropriate column heads and explanatory legends, including definitions of any abbreviation used. References used within tables should appear as footnotes in the table legend. These references should not be repeated in the main reference list unless they are also cited within the text. For footnotes, use the following symbols in this sequences: *, †, ‡, §, ||, ¶, **, †† .. Identify statistical measures of variations such as SD and SEM.
GUIDELINES FOR FIGURES AND ILLUSTRATIONS
Cite figures consecutively in the text, and number them in the order in which they are discussed. Figures must be submitted as individual files, choosing "figure" in the pull down menu in the “Attach file” step during the submission. Below it there is the "Description" box; where you should enter the figure number. Do not enter legends here, just the figure number. Please name figure files as fig. 1, fig. 2 etc. Always ensure that the file extension is present to ensure quick and easy format identification.
Clinical photographs (including those generated electronically from machines such as MRIs, fluorescein angiography, visual fields, etc.) must be masked to prevent identification of the patient. Clinical photographs that permit identification of an individual must be accompanied by a signed statement by the patient or guardian granting permission for publication of the pictures for educational purposes.
Do not embed figures in the Word document .
If figures are not submitted in a high enough resolution for publishing, they will be returned to the author.
Digital art should be created/scanned, saved and submitted as either a TIFF (tagged image file format) or an EPS (encapsulated postscript) file. Do not submit figures as PPT files (Powerpoint files). Electronic photographs and scanned images must have a resolution of at least 300 dpi . Line art must have a resolution of at least 1200 dpi. Any figure containing text should be saved only as TIFF file.
Black and white illustrations, graphs and figures files must be saved as tiff files in from the software used to create them setting the colour mode to greyscale and with a resolution of at least 600 dpi if text is included. If no text is included, set the resolution at a minimum of 300 dpi.
Color images must be created/scanned and saved and submitted as CMYK files, as it provides a better print copy for publishing. The physical dimensions of any artwork must fit within the dimensions of the pages within the Journal. (i.e., width no more than 10 cm)
No text should appear on the face of a figure. Lettering, arrows, and other symbols should be large enough to remain legible after reduction to a figure with a base of 10 cm. All symbols or letters that appear on the figures should be defined in the legend. Composites are recommended for figures in more parts (e.g., Fig 1A, 1B, 1C, 1D, 1E), labeled using typed text in a corner of the each image. Composite are encouraged for multipanel figures. Arial font should be used for any lettering or text on a figure. If possible use the same font type and size in all artworks (we recommend Arial 12).
If a figure has been published elsewhere, acknowledge the original source and submit written permission from the copyright holder to reproduce the material. Permission is required, regardless of authorship or publisher, except for documents in the public domain. Do not embed figures in a Word file and do not submit Powerpoint (PPT) figures. Always submit each figure as a separate file.
The Author should use colour figures only when necessary. If a manuscript has been submitted, reviewed and accepted with colour figures, then it MUST be published with colour figures. The Publisher charges authors directly for colour figures included in their manuscript. Colour figure charge is Euro 600,00 as start up fee plus Euro 80,00 for each additional figure. Authors will receive a colour charge form from the Publisher together with the galley proofs, to be signed prior to publication and will be invoiced after publication in print of the manuscript.
Form and contents should be very carefully checked to exclude the need for later corrections.
Manuscripts are assigned a unique number and all correspondence and enquiries regarding the manuscript must report this ID number. All manuscripts will be read by the Editor(s) and reviewed further by two reviewers. The Journal does not reveal the identity of its reviewers but does send pertinent comments back to the corresponding author. It is the Corresponding Author's responsibility to check periodically on the status of their manuscript.
A decision letter will be sent by email to the Corresponding author with detailed instructions if a revised version is required. Re-review may be required after revision. A point-by-point response is required to the reviewers' comments (full instructions will be provided in the decision letter).
If it is determined through the review process that your manuscript requires revision, you will receive an email containing all comments from the reviewers and instructions to submit your revision. The revised version must be submitted within 60 days from the date of the decision letter (30 days for case reports). Revisions not received within the allotted time will not be considered. If for any reason you decide not to revise your manuscript please make sure you log in as Author and click on the “Decline to revise” link, to notify the Editorial Office, Editor and Reviewers.
Log in as An Author with your username and password. The manuscript will be in the folder "Submissions needing revision".
- 1) Download all files which need revision by clicking on the "Download files" button. Do not work on the files stored in your own computer, but on the version available in the system, as sometimes minor stylistic changes are made.
- 2) Make changes to the text (remember to mark them in colour), figures, etc. according to the reviewers’ comments.
- 3) Using the Reference Checking tool supplied online correct all references which are not validated;
- 4) Prepare and save on your computer a point-by-point Response to Reviewers that clearly states how each issue raised by the reviewers has been covered and where it can be found (each reviewer's comment followed by the relative author reply, the page and line numbers where the changes have been made, using as a guide the pdf created by the system). All changes must be marked in colour in the manuscript file. You will not need to upload this file, but to copy and paste it in the space provided during the submission process of your revised submission.
When all files are revised as needed, log in again as an Author go to the folder "Submissions needing revision" and click on "Submit revision".
- 1) Submit the manuscript file and figure files revised according to the Reviewers’ comments,
- 2) Submit a point-by-point Response to Reviewers
Refer to the Author Tutorial supplied online which offers detailed instructions for revised submissions.
The Editors accept the manuscript with the understanding that the authors cooperate in a timely manner with the production process, including any response to future correspondence from Hip International or its readers. If accepted, the manuscript will be copyedited to conform with Editorial Board policy in accordance with the "Uniform requirements for manuscripts submitted to biomedical journals ". The corresponding author will receive typeset page proofs online and Author charges will be notified at proof stage directly by the Publisher.
The Corresponding author will receive an email of notification, complete with detailed instructions that proofs are ready for approval in their Author's folder in Editorial Manager for Hip International. Proofs must be reviewed carefully by more than one person and returned within 48 hours only through Editorial Manager for Hip International to avoid any delay. It is the Corresponding Author’s responsibility to ensure that there are no errors in the proofs. Changes that have been made to conform to journal style will stand if they do not alter the authors' meaning. Only the most critical changes to the accuracy of the content will be made. Changes that are stylistic or are a reworking of previously accepted material will be disallowed. The Publisher reserves the right to deny any changes that do not affect the accuracy of the content and Authors may be charged for alterations to the proofs beyond those required to correct errors or to answer queries. AUTHORSHIP CHANGES including adding or removing Authors CAN NOT BE SUBMITTED WITH PROOF CHANGES. The publisher is not authorized to make such changes and it will delay the publication of your manuscript (see Authorship criteria).
Extra-page charges apply. Each page exceeding the number of pages published by the Journal at no charge (see table above) will be charged € 130,00 directly by the Publisher and notified to the Corresponding Author with the proofs.
Extra page charges do not apply to invited articles and Editorials. Members of the European Hip Society and of the affiliated societies (SIA, SECCA, ACARO, SBQ, TOTBID) will be charged the reduced fee of Euro 100,00.
Authors will receive a reprint order form and a price list with the page proofs. Reprint requests should be returned with the corrected proofs. Reprints ordered post publication are subject to a surcharge of 40% to cover for additional production costs. Reprints are normally shipped 6 to 8 weeks after publication of the issue in which the item appears. For enquiries contact the Technical Editor of the Journal (firstname.lastname@example.org)
Accepted manuscript will be available online in the section "Article In Press" of the Journal after the proofs have been approved by the author. The only difference with the final published version is that the page numbers have not yet been assigned and when an article is assigned to an issue it will be removed from the section.
This early online release is not a draft version since it is produced after all editorial and author corrections are made but no routine editing will occur once the article is online. The publication online in the section “Articles in Press” is not meant to be a last editing opportunity for authors: however, if a major, critical error is found we may be able to make corrections prior to publication or an erratum will be published in a future issue. It is the Corresponding Author's responsibility that all editing be done when returning the corrected proofs to the publisher and that the publisher is notified immediately if the authors do not wish to have the article included in this section. All notifications regarding proof approvals, proof corrections or requests that an article not be released "in press" prior to publication must be made only through Editorial Manager for Hip Internatinal upon submission of the proof correction.
COPYRIGHT INFORMATIONThe use of published material for personal or institutional use (including reprinting, digital copies and transmission, display and web sharing) is subject to written authorization by the Publisher. For authorization requests, please send a request through the Journal's web site. The use of registered names, trade marks, etc. in this publication does not imply, even in absence of a specific statement, that such names are exempt from the relevant protective laws and regulations and therefore free for general use. Special regulations for the USAIn the USA copies may be made for personal or internal use, provided the required fee for copying beyond that permitted by Section 107 or 108 of the United States Copyright Law is paid through the Copyright Clearance Center, Inc. The copyright owner's consent does not extend to copying for general distribution, for promotion, for creating new works, or for resale. Specific written permission must be obtained from the publisher for such copying. DISCLAIMERThe statements and opinions contained in Hip International are solely those of the individual authors and contributors and do not necessarily reflect those of the Editors or the Publisher. The appearance of advertisements in the Journal is not a warranty, endorsement or approval of the products or services advertised or of their safety. The Publisher and the Editors disclaim responsibility for any injury to persons or property resulting from any ideas or products referred to in articles or advertisements.